{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:58:35Z","timestamp":1785527915694,"version":"3.56.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82401669"],"award-info":[{"award-number":["82401669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Oujiang Laboratory","award":["OJQD2022010"],"award-info":[{"award-number":["OJQD2022010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08367-5","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:10:55Z","timestamp":1785309055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment effects on sphingosine-1-phosphate and its receptors in major depressive disorder: implications for biomarkers"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anlong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyue","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"8367_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jad.2025.01.086","volume":"374","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qin C, Chen H, Liang W, Liu M, Liu J. Global, regional, and national burden of major depressive disorders in adults aged 60 years and older from 1990 to 2021, with projections of prevalence to 2050: Analyses from the Global Burden of Disease Study 2021. J Affect Disord. 2025;374:486\u201394.","journal-title":"J Affect Disord"},{"issue":"1","key":"8367_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1037\/neu0000717","volume":"35","author":"T Tran","year":"2021","unstructured":"Tran T, Milanovic M, Holshausen K, Bowie CR. What is normal cognition in depression? Prevalence and functional correlates of normative versus idiographic cognitive impairment. Neuropsychology. 2021;35(1):33\u201341.","journal-title":"Neuropsychology"},{"key":"8367_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-7682-3-1","volume":"3","author":"SE Lakhan","year":"2010","unstructured":"Lakhan SE, Vieira K, Hamlat E. Biomarkers in psychiatry: drawbacks and potential for misuse. Int archives Med. 2010;3:1.","journal-title":"Int archives Med"},{"issue":"7","key":"8367_CR4","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41380-021-01061-w","volume":"26","author":"H Le-Niculescu","year":"2021","unstructured":"Le-Niculescu H, Roseberry K, Gill SS, Levey DF, Phalen PL, Mullen J, Williams A, Bhairo S, Voegtline T, Davis H, et al. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2021;26(7):2776\u2013804.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"8367_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1017\/S1461145710000866","volume":"13","author":"EH Wong","year":"2010","unstructured":"Wong EH, Yocca F, Smith MA, Lee CM. Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters\u2019 perspective. Int J Neuropsychopharmacol. 2010;13(9):1269\u201384.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8367_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jad.2017.07.001","volume":"233","author":"BS Gadad","year":"2018","unstructured":"Gadad BS, Jha MK, Czysz A, Furman JL, Mayes TL, Emslie MP, Trivedi MH. Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks. J Affect Disord. 2018;233:3\u201314.","journal-title":"J Affect Disord"},{"issue":"1","key":"8367_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41398-022-02229-w","volume":"12","author":"JK Zaki","year":"2022","unstructured":"Zaki JK, Lago SG, Rustogi N, Gangadin SS, Benacek J, van Rees GF, Haenisch F, Broek JA, Suarez-Pinilla P, Ruland T, et al. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Translational psychiatry. 2022;12(1):457.","journal-title":"Translational psychiatry"},{"issue":"1","key":"8367_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41398-022-01918-w","volume":"12","author":"F Mamdani","year":"2022","unstructured":"Mamdani F, Weber MD, Bunney B, Burke K, Cartagena P, Walsh D, Lee FS, Barchas J, Schatzberg AF, Myers RM, et al. Identification of potential blood biomarkers associated with suicide in major depressive disorder. Translational psychiatry. 2022;12(1):159.","journal-title":"Translational psychiatry"},{"issue":"3 Suppl 1","key":"8367_CR9","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.metabol.2014.10.026","volume":"64","author":"M Kalia","year":"2015","unstructured":"Kalia M, Costa ESJ. Biomarkers of psychiatric diseases: current status and future prospects. Metabolism. 2015;64(3 Suppl 1):S11\u201315.","journal-title":"Metabolism"},{"issue":"5","key":"8367_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41380-019-0370-z","volume":"25","author":"H Le-Niculescu","year":"2020","unstructured":"Le-Niculescu H, Roseberry K, Levey DF, Rogers J, Kosary K, Prabha S, Jones T, Judd S, McCormick MA, Wessel AR, et al. Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs. Mol Psychiatry. 2020;25(5):918\u201338.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"8367_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40291-014-0108-1","volume":"18","author":"M Uddin","year":"2014","unstructured":"Uddin M. Blood-based biomarkers in depression: emerging themes in clinical research. Mol Diagn Ther. 2014;18(5):469\u201382.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"8367_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41398-018-0183-x","volume":"8","author":"JX Pan","year":"2018","unstructured":"Pan JX, Xia JJ, Deng FL, Liang WW, Wu J, Yin BM, Dong MX, Chen JJ, Ye F, Wang HY, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Translational psychiatry. 2018;8(1):130.","journal-title":"Translational psychiatry"},{"issue":"1","key":"8367_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41398-018-0245-0","volume":"8","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, Bai SJ, Li WW, Zhou CJ, Zheng P, Fang L, Wang HY, Liu YY, Xie P. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Translational psychiatry. 2018;8(1):192.","journal-title":"Translational psychiatry"},{"key":"8367_CR14","doi-asserted-by":"crossref","unstructured":"Hoertel N, M\u00fchle C, M\u00fcller CP, Chaieb H, Scheer V, Fayad M, S\u00e1nchez-Rico M, Limosin F, Kornhuber J. The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis. Mol Psychiatry. 2026.","DOI":"10.1038\/s41380-026-03649-6"},{"key":"8367_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jad.2017.02.008","volume":"213","author":"A Dinoff","year":"2017","unstructured":"Dinoff A, Herrmann N, Lanct\u00f4t KL. Ceramides and depression: A systematic review. J Affect Disord. 2017;213:35\u201343.","journal-title":"J Affect Disord"},{"issue":"7","key":"8367_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tips.2013.05.002","volume":"34","author":"C O\u2019Sullivan","year":"2013","unstructured":"O\u2019Sullivan C, Dev KK. The structure and function of the S1P1 receptor. Trends Pharmacol Sci. 2013;34(7):401\u201312.","journal-title":"Trends Pharmacol Sci"},{"key":"8367_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cellsig.2017.03.002","volume":"34","author":"SN Patmanathan","year":"2017","unstructured":"Patmanathan SN, Wang W, Yap LF, Herr DR, Paterson IC. Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. Cell Signal. 2017;34:66\u201375.","journal-title":"Cell Signal"},{"key":"8367_CR18","doi-asserted-by":"crossref","unstructured":"Tiper IV, East JE, Subrahmanyam PB, Webb TJ. Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection. Pathogens Dis. 2016;74(6).","DOI":"10.1093\/femspd\/ftw063"},{"key":"8367_CR19","doi-asserted-by":"crossref","unstructured":"Bravo G, Cede\u00f1o RR, Casadevall MP, Rami\u00f3-Torrent\u00e0 L. Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives. Cells. 2022;11(13).","DOI":"10.3390\/cells11132058"},{"key":"8367_CR20","doi-asserted-by":"crossref","unstructured":"Chatzikonstantinou S, Poulidou V, Arnaoutoglou M, Kazis D, Heliopoulos I, Grigoriadis N, Boziki M. Signaling through the S1P\u2013S1PR axis in the gut, the immune and the central nervous system in multiple sclerosis: implication for pathogenesis and treatment. Cells. 2021;10(11):3217.","DOI":"10.3390\/cells10113217"},{"key":"8367_CR21","doi-asserted-by":"crossref","unstructured":"Hla T, Brinkmann V. Sphingosine 1-phosphate (S1P). 2011;76(8_supplement_3):S3\u20138.","DOI":"10.1212\/WNL.0b013e31820d5ec1"},{"key":"8367_CR22","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Hern\u00e1ndez D, Mu\u00f1oz-L\u00f3pez M, Tendilla-Beltr\u00e1n H, Caso JR, Garc\u00eda-Bueno B, Mench\u00e9n L, Leza JC. Immune system and brain\/intestinal barrier functions in psychiatric diseases: is sphingosine-1-phosphate at the helm? Int J Mol Sci. 2023;24(16).","DOI":"10.3390\/ijms241612634"},{"issue":"4","key":"8367_CR23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/glia.24135","volume":"70","author":"SK Singh","year":"2022","unstructured":"Singh SK, Kordula T, Spiegel S. Neuronal contact upregulates astrocytic sphingosine-1-phosphate receptor 1 to coordinate astrocyte-neuron cross communication. Glia. 2022;70(4):712\u201327.","journal-title":"Glia"},{"key":"8367_CR24","doi-asserted-by":"crossref","unstructured":"Chen Z, Doyle TM, Luongo L, Largent-Milnes TM, Giancotti LA, Kolar G, Squillace S, Boccella S, Walker JK, Pendleton A, et al. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain. Proc Natl Acad Sci USA. 2019;116(21):10557\u201362.","DOI":"10.1073\/pnas.1820466116"},{"issue":"2","key":"8367_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","volume":"81","author":"J Chun","year":"2021","unstructured":"Chun J, Giovannoni G, Hunter SF. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects. Drugs. 2021;81(2):207\u201331.","journal-title":"Drugs"},{"issue":"1","key":"8367_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12974-017-0882-x","volume":"14","author":"SS Dusaban","year":"2017","unstructured":"Dusaban SS, Chun J, Rosen H, Purcell NH, Brown JH. Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes. J Neuroinflamm. 2017;14(1):111.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"8367_CR27","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1038\/s41467-019-10904-8","volume":"10","author":"BF Corbett","year":"2019","unstructured":"Corbett BF, Luz S, Arner J, Pearson-Leary J, Sengupta A, Taylor D, Gehrman P, Ross R, Bhatnagar S. Sphingosine-1-phosphate receptor 3 in the medial prefrontal cortex promotes stress resilience by reducing inflammatory processes. Nat Commun. 2019;10(1):3146.","journal-title":"Nat Commun"},{"key":"8367_CR28","doi-asserted-by":"crossref","unstructured":"Liu H, Chen S, Xiang H, Xiao J, Zhao S, Zhang X, Shu Z, Zhang J, Ouyang J, Liu Q, et al. S1PR3 in hippocampal neurons improves synaptic plasticity and decreases depressive behavior via downregulation of RhoA\/ROCK1. Prog Neuro-psychopharmacol Biol Psychiatry. 2025;137:111256.","DOI":"10.1016\/j.pnpbp.2025.111256"},{"key":"8367_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2024.12.001","volume":"124","author":"J Castro-Vildosola","year":"2025","unstructured":"Castro-Vildosola J, Bryan CA, Tajamal N, Jonnalagadda SA, Kasturi A, Tilly J, Garcia I, Kumar R, Fried NT, Hala T, et al. Sphingosine-1-phosphate receptor 3 activation promotes sociability and regulates transcripts important for anxiolytic-like behavior. Brain Behav Immun. 2025;124:205\u201317.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"8367_CR30","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00424-024-03012-0","volume":"476","author":"C Fischer","year":"2024","unstructured":"Fischer C, Thomas D, Gurke R, Tegeder I. Brain region specific regulation of anandamide (down) and sphingosine-1-phosphate (up) in association with anxiety (AEA) and resilience (S1P) in a mouse model of chronic unpredictable mild stress. Pflug Arch: Eur J Physiol. 2024;476(12):1863\u201380.","journal-title":"Pflug Arch: Eur J Physiol"},{"issue":"5","key":"8367_CR31","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/schbul\/sbaa052","volume":"46","author":"K Esaki","year":"2020","unstructured":"Esaki K, Balan S, Iwayama Y, Shimamoto-Mitsuyama C, Hirabayashi Y, Dean B, Yoshikawa T. Evidence for Altered Metabolism of Sphingosine-1-Phosphate in the Corpus Callosum of Patients with Schizophrenia. Schizophr Bull. 2020;46(5):1172\u201381.","journal-title":"Schizophr Bull"},{"issue":"1","key":"8367_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12916-024-03722-3","volume":"22","author":"L Fan","year":"2024","unstructured":"Fan L, Li Q, Shi Y, Li X, Liu Y, Chen J, Sun Y, Chen A, Yang Y, Zhang X, et al. Involvement of sphingosine-1-phosphate receptor 1 in pain insensitivity in a BTBR mouse model of autism spectrum disorder. BMC Med. 2024;22(1):504.","journal-title":"BMC Med"},{"key":"8367_CR33","doi-asserted-by":"crossref","unstructured":"Li Y, Squillace S, Schafer R, Giancotti LA, Chen Z, Egan TM, Hoft SG, DiPaolo RJ, Salvemini D. Contribution of S1pr1-featured astrocyte subpopulation to cisplatin-induced neuropathic pain in male mice. Pain. 2025.","DOI":"10.1097\/j.pain.0000000000003780"},{"key":"8367_CR34","doi-asserted-by":"crossref","unstructured":"Brunkhorst-Kanaan N, Trautmann S, Schreiber Y, Thomas D, Kittel-Schneider S, Gurke R, Geisslinger G, Reif A, Tegeder I. Sphingolipid and endocannabinoid profiles in adult attention deficit hyperactivity disorder. Biomedicines. 2021;9(9).","DOI":"10.3390\/biomedicines9091173"},{"issue":"1","key":"8367_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41398-022-01999-7","volume":"12","author":"C Zhuo","year":"2022","unstructured":"Zhuo C, Zhao F, Tian H, Chen J, Li Q, Yang L, Ping J, Li R, Wang L, Xu Y, et al. Acid sphingomyelinase\/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target. Translational psychiatry. 2022;12(1):260.","journal-title":"Translational psychiatry"},{"issue":"9","key":"8367_CR36","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"8367_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000506879","volume":"89","author":"D Carrozzino","year":"2020","unstructured":"Carrozzino D, Patierno C, Fava GA, Guidi J. The Hamilton Rating Scales for Depression: A Critical Review of Clinimetric Properties of Different Versions. Psychother Psychosom. 2020;89(3):133\u201350.","journal-title":"Psychother Psychosom"},{"issue":"6","key":"8367_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","volume":"102","author":"K Venkataraman","year":"2008","unstructured":"Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, Parikh NS, Habrukowich C, Hla T. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circul Res. 2008;102(6):669\u201376.","journal-title":"Circul Res"},{"key":"8367_CR39","doi-asserted-by":"publisher","first-page":"117043","DOI":"10.1016\/j.taap.2024.117043","volume":"490","author":"AS Elzaitony","year":"2024","unstructured":"Elzaitony AS, Al-Najjar AH, Gomaa AA, Eraque AMS, Sallam AS. Re-positioning of low dose paclitaxel against depressive-like behavior and neuroinflammation induced by lipopolysaccharide in rats: Crosstalk between NLRP3\/caspase-1\/IL-1beta and Sphk1\/S1P\/ NF-kappaB signaling pathways. Toxicol Appl Pharmacol. 2024;490:117043.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"8367_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4062\/biomolther.2024.200","volume":"33","author":"SS Yoo","year":"2025","unstructured":"Yoo SS, Kim Y, Lee DW, Ham HJ, Park JH, Yeo IJ, Chang JY, Yun J, Son DJ, Han SB, et al. Stress Accelerates Depressive-Like Behavior through Increase of SPNS2 Expression in Tg2576 Mice. Biomol Ther (Seoul). 2025;33(3):417\u201328.","journal-title":"Biomol Ther (Seoul)"},{"key":"8367_CR41","doi-asserted-by":"publisher","first-page":"118582","DOI":"10.1016\/j.lfs.2020.118582","volume":"263","author":"Y Guo","year":"2020","unstructured":"Guo Y, Gan X, Zhou H, Zhou H, Pu S, Long X, Ren C, Feng T, Tang H. Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation. Life Sci. 2020;263:118582.","journal-title":"Life Sci"},{"issue":"50","key":"8367_CR42","doi-asserted-by":"publisher","first-page":"E11721","DOI":"10.1073\/pnas.1811432115","volume":"115","author":"SJ Park","year":"2018","unstructured":"Park SJ, Kim JM, Kim J, Hur J, Park S, Kim K, Shin HJ, Chwae YJ. Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns. Proc Natl Acad Sci USA. 2018;115(50):E11721\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"8367_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1165\/rcmb.2012-0048OC","volume":"47","author":"X Sun","year":"2012","unstructured":"Sun X, Singleton PA, Letsiou E, Zhao J, Belvitch P, Sammani S, Chiang ET, Moreno-Vinasco L, Wade MS, Zhou T, et al. Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. Am J Respir Cell Mol Biol. 2012;47(5):628\u201336.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"8367_CR44","doi-asserted-by":"publisher","first-page":"110031","DOI":"10.1016\/j.isci.2024.110031","volume":"27","author":"H Matuskova","year":"2024","unstructured":"Matuskova H, Porschen LT, Matthes F, Lindgren AG, Petzold GC, Meissner A. Spatiotemporal sphingosine-1-phosphate receptor 3 expression within the cerebral vasculature after ischemic stroke. iScience. 2024;27(6):110031.","journal-title":"iScience"},{"issue":"6","key":"8367_CR45","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.arcmed.2022.08.002","volume":"53","author":"K Chen","year":"2022","unstructured":"Chen K, Wang Z, Liu C, Yang X, Jiang J. Sphingosine-1-phosphate Attenuates Endoplasmic Reticulum Stress-induced Cardiomyocyte Apoptosis Through Sphingosine-1-phosphate Receptor 1. Arch Med Res. 2022;53(6):562\u201373.","journal-title":"Arch Med Res"},{"key":"8367_CR46","doi-asserted-by":"publisher","first-page":"1516991","DOI":"10.3389\/fphar.2025.1516991","volume":"16","author":"S Chen","year":"2025","unstructured":"Chen S, Wu L, Lang B, Zhao G, Zhang W. Sphingosine 1-phosphate receptor 1 modulators exert neuroprotective effects in central nervous system disorders. Front Pharmacol. 2025;16:1516991.","journal-title":"Front Pharmacol"},{"issue":"5","key":"8367_CR47","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/jcpe.13780","volume":"50","author":"D Martin-Hernandez","year":"2023","unstructured":"Martin-Hernandez D, Martinez M, Robledo-Montana J, Munoz-Lopez M, Virto L, Ambrosio N, Marin MJ, Montero E, Herrera D, Sanz M, et al. Neuroinflammation related to the blood-brain barrier and sphingosine-1-phosphate in a pre-clinical model of periodontal diseases and depression in rats. J Clin Periodontol. 2023;50(5):642\u201356.","journal-title":"J Clin Periodontol"},{"key":"8367_CR48","doi-asserted-by":"crossref","unstructured":"Rossetti AC, Paladini MS, Trepci A, Mallien A, Riva MA, Gass P, Molteni R. Differential neuroinflammatory response in male and female mice: a role for BDNF. Front Mol Neurosci. 2019;12.","DOI":"10.3389\/fnmol.2019.00166"},{"issue":"10","key":"8367_CR49","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"8367_CR50","doi-asserted-by":"crossref","unstructured":"Knight EL, Majd M, Graham-Engeland JE, Smyth JM, Sliwinski MJ, Engeland CG. Gender differences in the link between depressive symptoms and ex vivo inflammatory responses are associated with markers of endotoxemia. Brain Behav Immun - Health. 2020;2.","DOI":"10.1016\/j.bbih.2019.100013"},{"key":"8367_CR51","doi-asserted-by":"crossref","unstructured":"Kim J, Kim JH, Chang KA. Sex difference in peripheral inflammatory biomarkers in drug-na\u00efve patients with major depression in young adulthood. Biomedicines. 2021;9(7):708.","DOI":"10.3390\/biomedicines9070708"},{"issue":"10","key":"8367_CR52","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00213-019-05326-9","volume":"236","author":"GM Slavich","year":"2019","unstructured":"Slavich GM, Sacher J. Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders. Psychopharmacology. 2019;236(10):3063\u201379.","journal-title":"Psychopharmacology"},{"issue":"1","key":"8367_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2643-3230.BCD-20-0200","volume":"2","author":"C Yang","year":"2021","unstructured":"Yang C, Yamashita M, Suda T. A Novel Function of Sphingolipid Signaling via S1PR3 in Hematopoietic and Leukemic Stem Cells. Blood cancer discovery. 2021;2(1):3\u20135.","journal-title":"Blood cancer discovery"},{"issue":"1","key":"8367_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12974-021-02092-4","volume":"18","author":"C Wang","year":"2021","unstructured":"Wang C, Xu T, Lachance BB, Zhong X, Shen G, Xu T, Tang C, Jia X. Critical roles of sphingosine kinase 1 in the regulation of neuroinflammation and neuronal injury after spinal cord injury. J Neuroinflamm. 2021;18(1):50.","journal-title":"J Neuroinflamm"},{"key":"8367_CR55","doi-asserted-by":"crossref","unstructured":"Gkesoglou T, Bargiota SI, Iordanidou E, Vasiliadis M, Bozikas VP, Agorastos A. Prognostic significance of blood-based baseline biomarkers in treatment-resistant depression: a literature review of available studies on treatment response. Brain Sci. 2022;12(7).","DOI":"10.3390\/brainsci12070940"},{"key":"8367_CR56","unstructured":"Wang L, Qiu Y, Bi L, Huang G, Ye P, Li S, Hongjun J. Molecular imaging of sphingosine-1-phosphate receptor 1 via PET tracer [18F]-TZ4877 in response to electro-puncture treatment for Alzheimer\u2019s disease. J NUCL MED. 2023;64(supplement 1):P1473\u20131473."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08367-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08367-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08367-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:15:43Z","timestamp":1785521743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08367-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8367"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08367-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research involving human participants and human material has been performed in accordance with the Declaration of Helsinki and approved by Clinical Experiment Ethics Committee of Lishui Second People\u2019s Hospital (Approval NO. 2023-028). For all research involving human participants, informed consent to participate in the study have been obtained from participants. For participants under 18 years of age, written informed consent was additionally obtained from their parents or legal guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"574"}}